Medical Research
(H30Z)
IRS Verified
DX Registered
990 on File
AMERICAN-ITALIAN CANCER FOUNDATION
Financial strength (30%)
74/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The American-Italian Cancer Foundation supports cancer research, education, and control, emphasizing the outstanding resources of Italy and the United States, recognizing world-class scientific excellence in medicine, and serving economically ?disadvantaged, medically under-served New York City women through breast cancer screening, outreach, and education.
Financial Overview — FY 2023
$2.3M
Total Revenue
$1.8M
Total Expenses
$5.7M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
94.4%
Fundraising Efficiency
42.5%
Operating Reserve
38.97x
Liability-to-Asset
2.8%
Revenue Diversification
97.3%
Executive Compensation
$175K
Compared with Peers
FY 2023
Compared with 481 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
94.4% | 82.4% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
3.1% | 12.0% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
2.6% | 1.0% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
42.5% | 135.9% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
39.0 mo | 15.1 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.8% | 11.5% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
97.3% | 93.0% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
37.9% | 7.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
18.7% | 12.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
23.5% | 0.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $2.3M | $1.8M | $5.7M | 94.4% | 0 |
| 2022 | $1.7M | $1.5M | $5.1M | 95.6% | 0 |
| 2021 | $1.1M | $1.1M | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.